Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wolco Invest is a Polish investment and holding company primarily focused on the life sciences and biotechnology sectors. Founded by Dr. Maciej Wieczorek, a prominent entrepreneur and scientist in the Polish pharmaceutical industry, the company serves as a strategic investment vehicle for major biotech entities such as Mabion S.A. and Celon Pharma S.A. Wolco Invest plays a critical role in the financing, strategic development, and corporate governance of its portfolio companies, which specialize in biosimilars and innovative small molecule therapeutics. The company is headquartered in Łódź, Poland, and is central to the growth of the Polish biotechnology ecosystem. Through its holdings, Wolco Invest supports the development of treatments for oncology, autoimmune disorders, and respiratory diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wolco Invest.